| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Donohue James J. serves as a Director at ACXP. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $33K at current prices.
The biggest single holding is ACXP (~$33K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 9,852 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | ACXP Acurx Pharmaceuticals, Inc. | Director | Buy | 9,852 | $1.02 | $9,999.78 | +78.8% | -69.9% | -86.6% |